Genus plc (LON:GNS – Get Free Report)’s stock price passed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of GBX 2,569.03 and traded as low as GBX 2,060. Genus shares last traded at GBX 2,079.90, with a volume of 286,615 shares trading hands.
Analysts Set New Price Targets
Separately, Berenberg Bank reiterated a “buy” rating and set a GBX 3,350 price objective on shares of Genus in a research report on Monday, May 11th. Three equities research analysts have rated the stock with a Buy rating, According to MarketBeat, the stock currently has an average rating of “Buy” and a consensus target price of GBX 3,216.67.
Genus Price Performance
Insiders Place Their Bets
In other news, insider Jorgen Kokke sold 3,450 shares of the company’s stock in a transaction on Wednesday, May 13th. The stock was sold at an average price of GBX 2,267, for a total transaction of £78,211.50. Also, insider Celia Baxter purchased 2,336 shares of the firm’s stock in a transaction that occurred on Friday, June 26th. The stock was bought at an average price of GBX 2,140 per share, with a total value of £49,990.40. 0.71% of the stock is owned by insiders.
Genus Company Profile
Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells breeding pigs and semen to breed pigs with various characteristics for pork production under the PIC brand. The company also sells bull semen and embryos to breed calves with various characteristics for milk and beef production under the ABS, Genus, and Bovec brands.
Further Reading
- Five stocks we like better than Genus
- Apple and Broadcom Forge a Decade-Long Silicon Fortress
- SK Hynix’s Nasdaq Listing Could Reset the AI Memory Trade
- The AI Chip Sell-Off Looks Scary, But the Real Story May Be Liquidity
- Palantir’s CEO Just Called Out OpenAI and Anthropic
Receive News & Ratings for Genus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genus and related companies with MarketBeat.com's FREE daily email newsletter.
